Sfoglia per Rivista DIABETES, OBESITY AND METABOLISM
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
2017-01-01 Pozzilli, P; Norwood, P; Jódar, E; Davies, Mj; Ivanyi, T; Jiang, H; Woodward, Db; Milicevic, Z
Review of clinical trials: update on oral insulin spray formulation
2010-01-01 Pozzilli, P; Raskin, P; Parkin, Cg
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9). | 1-gen-2017 | Pozzilli, P; Norwood, P; Jódar, E; Davies, Mj; Ivanyi, T; Jiang, H; Woodward, Db; Milicevic, Z | |
Review of clinical trials: update on oral insulin spray formulation | 1-gen-2010 | Pozzilli, P; Raskin, P; Parkin, Cg |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile